Search Results 881-890 of 17091 for egfr

  1. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    About this study. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...

  2. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  3. Cirrhosis Clinical Trials - Mayo Clinic Research

    Erlotinib (Tarceva) is a human EGFR type 1 tyrosine kinase inhibitor and offers greater survival benefit to EGFR positive patients. This study will assist ...

  4. Publications - Jeremy C. Jones, M.D. - Mayo Clinic

    Activity of EGFR antibody in non-V600 BRAF mutant metastatic colorectal cancer. Ann Oncol 2019 Jan 1; 30 (1):147-149. View PubMed; Jones JC, Renfro LA, Al ...

  5. Resources - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    National Human Genome Research Institute: Polygenic risk scores. CanRisk breast and ovarian cancer risk calculator. Publications. The eMERGE Network recommends ...

  6. Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease - Mayo Clinic

    This study will use a 22 gene pharmacogenomics panel on 30 children with persistent Gastroesophageal Reflux Disease (GERD) who have not responded to therapy.

  7. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  8. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  9. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  10. A Study to Evaluate the Safety and Tolerability of HMPL-306 to Treat Advanced or Metastatic Solid Tumors with IDH Mutations - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability, and preliminary effectiveness of HMPL-306 in advanced or metastatic solid tumors with IDH ...